Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Mr. Michael Jordan Friedman J.D., L.L.M.

Market Cap

31.10 Million USD

Sector

Healthcare

Website

https://innovativemedtechinc.com

Description

Innovative MedTech Inc.

Read More

Overview

Value

1

Growth

36

Health

22

Management

60

Analyst Opinion

54

Total

35

All Scores Out Of 100

Best Features

  • Earnings growth has improved recently
  • Has a low level of debt
  • Low preportion of income is paid as dividend
  • 0

Risk Factors

  • Overvalued on cashflow basis
  • Income is not covering expenditure and investment
  • Earnings are negative
  • There is a history of diluting shareholders
  • Does not hold enough liquid assets to cover short term liabilities
  • Poor overall financial health
  • No margin of safety at their current market price
  • Poor earnings and cashflow growth

Market Peers

IMTH

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

-10346539.36%

Revenue Growth (5 Year Average)

N/A

Ratings Consensus

Neutral

Share Buybacks

-653.80%

Dividend Yeild (TTM)

N/A

Valuation

Value Score

1

  • Estimated intrinsic-value of NaN undefined USD is lower than current price ( 1.47 USD)
  • Free-cashflow-yeild of -1.95% is worse than the market average (4.7%)
  • Margin-of-safety of -10346539.36% is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: N/A

Current Price: 1.5 USD

Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

-1.95%

PE/Earnings Growth

N/A

Price/Book

-12.90x

Growth

Growth Score

36

  • 5 Year Average Earnings growth of 17.84% is higher than the market average (14.48%)
  • Earnings growth has improved this year
  • 5 Year Average Revenue growth of N/A is lower than the market average (10.97%)
  • Revenue growth has slowed this year
  • 5 Year Average Free Cashflow growth of N/A is lower than the market average (12.35%)
  • Free Cashflow growth has slowed this year

Revenue Growth

N/A

Earnings Growth

17.84%

Cashflow Growth

N/A

Health

Health Score

22

  • Has a low level of debt
  • Cashflow is negative
  • Assets do not cover liabilities
  • High financial leverage and base interest rate exposure
  • Requires debt for normal operation to be sustainable
  • Debt repayments significantly impact cashflow

Altman Z Score

N/A

Piostroski Score

N/A

Debt/Equity

N/Ax

Current Assets/Liabilities

0.13x

Free Cashflow/Total Debt

N/Ax

Debt/Capital

3.87x

Management

Management Score

60

  • Has issued new shares to finance growth when share price is high
  • Return-on-equity of 1635.06% is higher than the market average (15%)
  • Return-on-capital-employed of -207.01% is lower than the market average (10%)
  • Has a history of diluting shareholders to finance activity

Average Buybacks/Dilution

-653.80%

Recent Buybacks/Dilution

27.42%

5 Year Price Volitility

225.61%

Return On Assets

-480.44%

Return On Capital Employed

-207.01%

Return On Equity

1635.06%

Return On Free Cashflow

-82069.24%

Return On Investments

N/A

Analysts

Analyst Opinion

54

  • Ratings consensus is Neutral

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

Innovative MedTech Inc.

Currency

USD

Beta

-0.100802

Vol Avg

35

Ceo

Mr. Michael Jordan Friedman J.D., L.L.M.

Cik

0001331612

Cusip

45782W108

Exchange

Other OTC

Full Time Employees

40

Industry

Medical Instruments & Supplies

Sector

Healthcare

Ipo Date

2007-05-08

Address

2310 York Street

City

Blue Island

State

IL

Country

US

Zip

60406

Phone

708 925 9424

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies